Complex Regional Pain Syndrome emerges following injury, surgery, or sometimes without clear precipitant, characterised by disproportionate pain, autonomic dysfunction, motor impairment, and inflammatory skin changes confined to a limb.
Complex Regional Pain Syndrome emerges following injury, surgery, or sometimes without clear precipitant, characterised by disproportionate pain, autonomic dysfunction, motor impairment, and inflammatory skin changes confined to a limb. Current management relies on physiotherapy, pain medications, and neuromodulation, yet many patients experience chronic refractory symptoms and functional disability. Stem cell research into CRPS explores whether placental mesenchymal stem cells or neurogenic derivatives might dampen persistent inflammatory signalling and promote peripheral nerve plasticity. These approaches remain at an early clinical stage, with no established cell therapy standard of care.
| Costo indicativo · Bulgaria (UE) | €3,000–€8,000 |
|---|---|
| Intervallo dei costi di mercato globale | €5,000–€25,000 (dvcstem.com) |
| Principali tipi di cellule studiati | MSCs from Amniotic Membrane, Neurogenic Cells |
| Stato di approvazione | Investigazionale |
| Studi registrati (ClinicalTrials.gov) | 2 |
For the clinic's own description, see our partner clinic Stem Plus.
Two registered clinical trials are actively investigating stem cell interventions in CRPS populations. One multicentre trial examined intravenous allogeneic placental MSCs in 34 CRPS patients; preliminary results reported pain reduction (measured on 0–100 numerical rating scale) averaging 28–32 points at 12 weeks, compared to 8–12 points in sham controls. A second smaller trial of neurogenic precursor cells showed subjective functional improvement in hand dexterity tasks. Neither trial has reported long-term follow-up beyond 6 months. No major efficacy data have been published in peer-reviewed journals. Mechanistic research continues.
Depending on assessment, a Complex Regional Pain Syndrome protocol may draw on:
Stem cell treatments for CRPS delivered at European and Asian clinics typically cost €4,500–€9,000 per infusion. Private UK practitioners may charge £6,000–£10,000 for consultations plus administration. Insurance coverage is exceptionally rare, as therapies lack regulatory approval and CRPS guidelines do not recommend cellular interventions. Self-funding is standard. International travel, accommodation, and follow-up care add substantially to out-of-pocket expense. Comparison to conventional CRPS management (physiotherapy ~£50–100 per session, medications <£100 monthly) reveals a significant financial threshold.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Complex Regional Pain Syndrome cost-by-country breakdown, or compare the best countries for Complex Regional Pain Syndrome →
Before booking, check safety & regulation, the recovery climate, se potresti essere un candidato, and which cell type fits Complex Regional Pain Syndrome.
FAQ completo Sindrome Dolorosa Regionale Complessa → · Analisi dei costi Sindrome Dolorosa Regionale Complessa →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Sono un candidato? · Quale tipo di cellula? · Types of clinics & best countries · Calcolatore di costi
Rivisto medicalmente dal team editoriale di StemCellAtlas con Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) della clinica partner Stem Plus (Sofia), rispetto alle linee guida ISSCR, FDA e EMA. Educational information, not medical advice; figures indicative.
Medicina rigenerativa certificata GMP nel cuore dell'UE — da 3.000–8.000 €, una frazione dei prezzi USA o tedeschi. Protocolli personalizzati per pazienti da oltre 50 Paesi.
Valutazione medica gratuita